|
|
||||||||
Eur J Cardiothorac Surg 2004;25:275-280
© 2004 Elsevier Science NL
a Second Department of Surgery, Ehime University School of Medicine, Shitsukawa, Shigenobucho, Onsengun, Ehime 791-0295, Japan
b Department of Pharmacology, Ehime University School of Medicine, Ehime, Japan
Received 18 June 2003; received in revised form 24 September 2003; accepted 11 November 2003.
* Corresponding author. Tel.: +81-89-960-5331; fax: +81-89-960-5335
e-mail: tsunooka{at}m.ehime-u.ac.jp
Objective: To demonstrate that small intestinal mucosal ischemia occurs during cardiopulmonary bypass by measuring serum diamine oxidase activity, an index of small intestinal mucosal ischemia, in perioerative patients undergoing cardiovascular surgery with and without cardiopulmonary bypass. Methods: Twelve successive patients who underwent coronary artery bypass grafting with cardiopulmonary bypass (Group I) were compared to 10 patients who underwent off-pump coronary artery bypass grafting (Group II). Serum diamine oxidase activity, blood lactate concentration, and serum peptidoglycan concentration were measured perioperatively. Results: Serum diamine oxidase activity rose after the start of cardiopulmonary bypass and continued to rise throughout cardiopulmonary bypass in Group I, while activity was unchanged in Group II. The serum lactate concentration mirrored the change in the diamine oxidase activity in both groups. The peptidoglycan concentration in Group I rose after the start of cardiopulmonary bypass and returned to near normal concentrations after surgery. Conclusions: The parallel rise in diamine oxidase activity and the serum lactate concentration in Group I implies that ischemic injury to the mucosa of the small intestine occurs during cardiopulmonary bypass, and the rise in the serum peptidoglycan concentration indicates that bacteremia did occur. Thus, cardiopulmonary bypass causes hypoperfusion of small intestinal mucosa and consequently bacterial translocation.
Key Words: Cardiopulmonary bypass Ischemia of small intestinal mucosa Diamine oxidase Peptidoglycan Bacterial translocation
This article has been cited by other articles:
![]() |
R. K. P. Adluri, A. V. Singh, J. Skoyles, A. Robins, A. Hitch, M. Baker, and I. M. Mitchell The effect of fenoldopam and dopexamine on hepatic blood flow and hepatic function following coronary artery bypass grafting with hypothermic cardiopulmonary bypass Eur. J. Cardiothorac. Surg., June 1, 2009; 35(6): 988 - 994. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Hadley, J. E. Wang, S. J. Foster, C. Thiemermann, and C. J. Hinds Peptidoglycan of Staphylococcus aureus Upregulates Monocyte Expression of CD14, Toll-Like Receptor 2 (TLR2), and TLR4 in Human Blood: Possible Implications for Priming of Lipopolysaccharide Signaling Infect. Immun., November 1, 2005; 73(11): 7613 - 7619. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-y. Xia, X.-Y. Liu, L.-y. Zhan, Y.-h. He, T. Luo, and Z. Xia Ginsenosides compound (shen-fu) attenuates gastrointestinal injury and inhibits inflammatory response after cardiopulmonary bypass in patients with congenital heart disease J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 258 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Djaiani, L. Fedorko, and W. S. Beattie Regional Anesthesia in Cardiac Surgery: A Friend or A Foe? Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2005; 9(1): 87 - 104. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |